CRISPR-based Gene Editing Market, By Product & Service, By Application, By End Use, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

CRISPR-based Gene Editing Market size was valued at US$ 4,605.2 Million in 2025, expanding at a CAGR of 15.1% from 2026 to 2033.

CRISPR-based gene editing refers to a set of advanced biotechnology tools used to precisely modify DNA sequences within living organisms. It enables researchers to add, remove, or alter genetic material at specific locations, improving accuracy and efficiency in genetic engineering. The CRISPR-based Gene Editing market represents a major advancement in molecular biology and biotechnology, enabling highly precise and efficient genome modification. For instance, in 2025, research on advancements in molecular biology by NIH.gov highlights that modern molecular biology has expanded to analyze biological systems at single-cell resolution, enabling detection of gene expression variability across thousands to millions of individual cells per experiment, compared to earlier bulk-level methods that averaged signals across entire tissues. This precision is expected to accelerate innovation and expand CRISPR adoption in therapeutics.

CRISPR-based Gene Editing Market- Market Dynamics

Rising prevalence of genetic disorders to propel market demand

The rise of genetic disorders is driving increased research into rare and previously undiagnosed neurodevelopmental conditions, supported by advances in genome sequencing and clinical genomics. Recent discoveries, including newly identified mutations in genes such as RPS6KC1, are expanding understanding of complex neurological and developmental diseases. These advancements are strengthening early diagnosis capabilities and accelerating the development of targeted therapies for rare genetic disorders.

The rising prevalence of genetic disorders globally is driving demand for CRISP based gene editing, as it enables precise correction of disease-causing mutations and supports the development of targeted, next-generation genetic therapies. For instance, in 2026, insights from the CDC Gov., genomics, and health overview highlight that genetic disorders arise from changes in DNA ranging from single-gene mutations to chromosomal abnormalities and complex interactions between multiple genes and environmental factors. The CDC reports that rare and genetic conditions include single-gene and chromosomal disorders such as Down syndrome (~1 in 700 births) and diseases like cystic fibrosis affecting ~35,000 people in the U.S. Thus, accelerating CRISPR adoption for precise, personalized, and potentially curative genetic disease therapies.

CRISPR-based Gene Editing Market- Segmentation Analysis:

The Global CRISPR-based Gene Editing Market is segmented on the basis of Product & Service , Application, End Use, and Region.

From a product & service perspective, CRISPR kits & reagents hold a significant share in the CRISPR-based Gene Editing market due to their widespread use in genome editing workflows, high research adoption, and essential role in gene modification. For instance, research by the Department of Pharmaceuticals, Government of India, highlights that the growing demand for kits and reagents is significantly contributing to the expansion of India's medical devices industry. The report states that India's import dependence on IVD reagents increased by nearly 65.4%, reaching around USD 872 million due to rising diagnostic testing demand. Additionally, medical device imports touched approximately USD 8,500 million, growing by 36.8% with expanding healthcare screening and testing infrastructure. Thus, expanding diagnostic and research applications are accelerating global demand for CRISPR kits and reagents.

In terms of application, the biomedical segment represents a key area in the CRISPR-based Gene Editing market, driven by its expanding use in therapeutic development, genetic disorder treatment, oncology research, disease diagnostics, and the growing adoption of ex vivo and in vivo gene editing technologies. For instance, in 2025, research by the OECD org. highlights that Japan is witnessing growing use of biomedical and advanced healthcare technologies. Japan spends around 10.6% of GDP on healthcare, with per capita healthcare expenditure reaching nearly USD 5,790 and universal coverage for 100% of the population. The country also has approximately 184 CT, MRI, and PET scanners per million people and around 203 pharmacists per 100,000 population, reflecting strong adoption of advanced healthcare technologies. The expanding healthcare infrastructure is accelerating biomedical adoption in the CRISPR-based Gene Editing market.

CRISPR-based Gene Editing Market- Geographical Insights

North America holds a key position in the CRISPR-based Gene Editing market, driven by the presence of key biotechnology and pharmaceutical companies and continuous investments in research and development. In April 2025, Danaher Corporation advanced its CRISPR-based gene editing capabilities by strengthening its research and development ecosystem through Integrated DNA Technologies (IDT) and Aldevron, focusing on high-quality DNA, RNA, and CRISPR tool production to accelerate development of next-generation gene editing therapies and improve scalability of personalized treatment solutions. And this strengthens North America's leadership in CRISPR innovation and therapeutic development.

Moreover, Asia-Pacific is expected to grow at a rapid pace in the CRISPR-based Gene Editing market, supported by the expansion of biotechnology and pharmaceutical industries. Countries such as China, Japan, South Korea, and India are making significant investments in genomic research, clinical trials, and CRISPR-based product development, driven by supportive government initiatives and progressive policy reforms. In May 2025, as stated by PIB Gov., at the Bharat Ratna C. Subramaniam Auditorium, NASC Complex, New Delhi, Union Agriculture and Farmers Welfare Minister Shri Shivraj Singh Chouhan launched India's first genome-edited rice varieties, DRR Rice 100 (Kamla) and Pusa DST Rice 1. Developed by ICAR using CRISPR-based genome editing, these varieties offer higher yield, improved climate adaptability, and better water conservation. With this launch, India became the first country to develop genome-edited rice varieties. Therefore, Asia-Pacific is leading CRISPR adoption through strong innovation and policy support.

China plays a key role in the CRISPR-based Gene Editing market, being the first country to conduct human clinical trials using CRISPR-Cas9 for genetic disorders. For instance, the NIH Gov. highlights that China's modern clinical trial system has rapidly expanded from minimal participation in early controlled human studies to a large-scale multicenter randomized clinical research ecosystem. By the structured clinical research phase, China had established hundreds of multicenter RCTs across major therapeutic areas, including oncology, cardiovascular, infectious diseases, and traditional medicine. Modern trials now involve several hundred to over 3,000 participants per Phase II/III study, up from fewer than 100 participants in earlier decades. Thus, China's clinical expansion is accelerating CRISPR gene editing advancements.

CRISPR-based Gene Editing Market- Competitive Landscape:

The CRISPR-based Gene Editing market is highly competitive and moderately consolidated, with several global and specialized biotechnology players driving innovation and commercialization. Leading companies such as CRISPR Therapeutics AG, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., GeneCopoeia, Inc., and Synthego Corporation are strengthening their positions through advanced genome editing platforms, expanding research applications, and continuous product development in gene modification technologies. In May 2025, Danaher used its Business System to deliver the world's first mRNA-based personalized CRISPR therapy in under six months, accelerating treatment for a child with neonatal-onset CPS1 deficiency. Hence, ongoing innovation is accelerating CRISPR therapy development and clinical adoption globally.

Recent Developments:

In May 2025, Bio-Techne Corporation entered into a collaboration with Kytopen to integrate Flowfect(R) continuous flow technology with advanced gene delivery systems, enabling scalable non-viral CRISPR-mediated T-cell engineering and improving efficiency in cell therapy manufacturing workflows.

In April 2025, Synthego Corporation expanded its CRISPR licensing ecosystem through a strategic agreement with Vita Therapeutics to integrate high-fidelity hfCas12Max nuclease technology into next-generation cell therapy programs, enhancing precision and reducing off-target gene editing risks.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRISPR-BASED GENE EDITING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Revvity, Inc.
Danaher Corporation
GenScript Biotech Corporation
Merck KGaA
Thermo Fisher Scientific, Inc.
Tocris Bioscience
OriGene Technologies, Inc.
Bio-Rad Laboratories
Bio-Techne Corporation
New England Biolabs, Inc.
CRISPR Therapeutics AG
Agilent Technologies, Inc.
GeneCopoeia, Inc.
Synthego Corporation
System Biosciences LLC
ToolGen, Inc.
Rockland Immunochemicals, Inc.
Horizon Discovery Group
Abcam, Inc.
Applied StemCell, Inc.
Cellecta, Inc.
Others

GLOBAL CRISPR-BASED GENE EDITING MARKET, BY PRODUCT & SERVICE - MARKET ANALYSIS, 2020 - 2033

Products
CRISPR Libraries
CRISPR Kits & Reagents
Others
Services
Others

GLOBAL CRISPR-BASED GENE EDITING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

By Delivery Method
Ex Vivo
In Vivo
Disease Diagnostics
Agricultural applications
Farm Animals Engineering
Plant Engineering
Others
Biomedical
Therapeutic Development
By Indication
Ophthalmology
Oncology
Genetic Disorders
Others

GLOBAL CRISPR-BASED GENE EDITING MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033

Contract Research Organizations
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Others

GLOBAL CRISPR-BASED GENE EDITING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

Product Code: ANV6595

1. CRISPR-based Gene Editing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. CRISPR-based Gene Editing Market Snippet by Product & Service
- 2.1.2. CRISPR-based Gene Editing Market Snippet by Application
- 2.1.3. CRISPR-based Gene Editing Market Snippet by End Use
- 2.1.4. CRISPR-based Gene Editing Market Snippet by Country
- 2.1.5. CRISPR-based Gene Editing Market Snippet by Region
2.2. Competitive Insights

3. CRISPR-based Gene Editing Key Market Trends

3.1. CRISPR-based Gene Editing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. CRISPR-based Gene Editing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. CRISPR-based Gene Editing Market Opportunities
3.4. CRISPR-based Gene Editing Market Future Trends

4. CRISPR-based Gene Editing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. CRISPR-based Gene Editing Market : Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. CRISPR-based Gene Editing Market Landscape

6.1. CRISPR-based Gene Editing Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. CRISPR-based Gene Editing Market - By Product & Service

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product & Service , 2025 & 2033 (%)
- 7.1.2. Products
  - 7.1.2.1. CRISPR Libraries
  - 7.1.2.2. CRISPR Kits & Reagents
  - 7.1.2.3. Others
- 7.1.3. Services
- 7.1.4. Others

8. CRISPR-based Gene Editing Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 8.1.2. By Delivery Method
  - 8.1.2.1. Ex Vivo
  - 8.1.2.2. In Vivo
- 8.1.3. Disease Diagnostics
- 8.1.4. Agricultural applications
  - 8.1.4.1. Farm Animals Engineering
  - 8.1.4.2. Plant Engineering
  - 8.1.4.3. Others
- 8.1.5. Biomedical
  - 8.1.5.1. Therapeutic Development
  - 8.1.5.1.1. By Indication
  - 8.1.5.1.2. Ophthalmology
  - 8.1.5.1.3. Oncology
  - 8.1.5.1.4. Genetic Disorders
  - 8.1.5.1.5. Others

9. CRISPR-based Gene Editing Market - By End Use

9.1. Overview
- 9.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
- 9.1.2. Contract Research Organizations
- 9.1.3. Academic & Research Institutes
- 9.1.4. Pharmaceutical & Biotechnology Companies
- 9.1.5. Others

10. CRISPR-based Gene Editing Market - By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. CRISPR-based Gene Editing Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. CRISPR-based Gene Editing Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.8. UK
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.8.3. UK Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.8.5. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.9. France
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.9.3. France Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.9.5. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.10. Italy
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.10.3. Italy Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.10.5. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.11. Spain
  - 10.3.11.1. Overview
  - 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.11.3. Spain Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.11.5. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.12. The Netherlands
  - 10.3.12.1. Overview
  - 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.12.3. The Netherlands Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.12.5. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Overview
  - 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.13.5. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.14. Russia
  - 10.3.14.1. Overview
  - 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.14.3. Russia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.14.5. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.15. Poland
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.15.3. Poland Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.15.5. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.16. Denmark
  - 10.3.16.1. Overview
  - 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.16.3. Denmark Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.16.5. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.17. Rest of Europe
  - 10.3.17.1. Overview
  - 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.17.3. Rest of the Europe Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.17.5. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. CRISPR-based Gene Editing Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.7. China
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.7.3. China Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.7.5. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.8. India
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.8.3. India Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.8.5. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.12. Indonesia
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.12.3. Indonesia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.12.5. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.13. Thailand
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.13.3. Thailand Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.13.5. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.15. Taiwan
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.15.3. Taiwan Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.15.5. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.16. Vietnam
  - 10.4.16.1. Overview
  - 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.16.3. Vietnam Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.16.5. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.17. Rest of APAC
  - 10.4.17.1. Overview
  - 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.17.3. Rest of APAC Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.17.5. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. CRISPR-based Gene Editing Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. CRISPR-based Gene Editing Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.8. UAE
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.8.3. UAE Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.8.5. UAE Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.13. Iran
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.13.3. Iran Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.13.5. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.14. Qatar
  - 10.6.14.1. Overview
  - 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.14.3. Qatar Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.14.5. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.15. Rest of MEA
  - 10.6.15.1. Overview
  - 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.15.3. Rest of MEA Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
  - 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.15.5. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- CRISPR-based Gene Editing Industry

11.1. Competitive Benchmarking
- 11.1.1. Competitive Dashboard
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Revvity, Inc.
- 11.2.2. Danaher Corporation
- 11.2.3. GenScript Biotech Corporation
- 11.2.4. Merck KGaA
- 11.2.5. Thermo Fisher Scientific, Inc.
- 11.2.6. Tocris Bioscience
- 11.2.7. OriGene Technologies, Inc.
- 11.2.8. Bio-Rad Laboratories
- 11.2.9. Bio-Techne Corporation
- 11.2.10. New England Biolabs, Inc.
- 11.2.11. CRISPR Therapeutics AG
- 11.2.12. Agilent Technologies, Inc.
- 11.2.13. GeneCopoeia, Inc.
- 11.2.14. Synthego Corporation
- 11.2.15. System Biosciences LLC
- 11.2.16. ToolGen, Inc.
- 11.2.17. Rockland Immunochemicals, Inc.
- 11.2.18. Horizon Discovery Group
- 11.2.19. Abcam, Inc.
- 11.2.20. Applied StemCell, Inc.
- 11.2.21. Cellecta, Inc.
- 11.2.22. Others

12. 360 Degree AnalystView

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us